Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging: Berlin Monday, January 13, 202 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback